Biolex files for $70 mln IPO
Aug 14 (Reuters) - Clinical-stage biopharmaceutical company Biolex Inc. said it filed with U.S. regulators to raise up to $70 million in an initial public offering of common stock. The Pittsboro, North Carolina-based company said it applied for listing on the Nasdaq under the symbol "BLEX".
Lehman Brothers Inc. and Deutsche Bank Securities Inc. are acting as joint book-running managers, Biolex added. (Reporting by Esha Dey in Bangalore)
Trending On Reuters
We are living longer but not creating financial plans to keep pace. Advisers give tips on how to make sure you don’t outlive your money. Video